Android app Apple app link

Stoke Therapeutics, Inc. (STOK) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$35.52
Day's range
$38.69

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/30/2026 Goldman Sachs Kevin Strang $43.00 $26.35   63.19%
08/04/2026 Canaccord Genuity Sumant Kulkarni $58.00 $29.56   96.21%
07/13/2026 Goldman Sachs Kevin Strang $44.00 $31.38   40.22%
02/05/2026 Guggenheim Yatin Suneja $60.00 $32.00   87.5%
01/05/2026 Loop Capital Markets Keay Nakae $35.00 $30.90   13.27%
12/16/2025 H.C. Wainwright Andrew Fein $50.00 $32.90   51.98%
08/18/2025 BTIG Thomas Shrader $28.00 $18.10   54.7%
10/11/2024 Leerink Partners Marc Goodman $18.00 $11.84   52.03%
09/11/2024 H.C. Wainwright Debjit Chattopadhyay $35.00 $15.32   128.46%
05/07/2024 Canaccord Genuity Sumant Kulkami $20.00 $11.87   68.49%
03/26/2024 Needham Joseph Stringer $22.00 $6.50   238.46%
03/26/2024 Canaccord Genuity Sumant Kulkami $21.00 $10.92   92.31%
04/25/2021 Credit Suisse Judah Frommer $58.00 $32.50   78.46%

Stoke Therapeutics Inc FAQ's

Stoke Therapeutics Inc has been rated by research analysts at Goldman Sachs, Canaccord Genuity, Wolfe Research, Guggenheim, Wedbush, Loop Capital Markets in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.